L-type Ca2+ channels in the heart: Structure and regulation

Medicina

Volumn 44, Issue 7, 2008, Pages 491-499

  Treinys, Rimantas ^a   Jureviĉius, Jonas ^a  

^a KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

Author keywords

Ca2+ channels; Facilitation; Inactivation; Kinases; Phosphorylation

Indexed keywords

CALCIUM; CALCIUM CHANNEL L TYPE; ISOPROTEIN; PROTEIN KINASE; PROTEIN TYROSINE KINASE;

ANIMAL; CHANNEL GATING; COMPARATIVE STUDY; CYTOPLASM; DOG; FROG; GUINEA PIG; HEART CONTRACTION; HEART DISEASE; HEART FAILURE; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RABBIT; REVIEW; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM; CALCIUM CHANNELS, L-TYPE; CYTOPLASM; DOGS; GUINEA PIGS; HEART DISEASES; HEART FAILURE; HUMANS; ION CHANNEL GATING; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN KINASES; PROTEIN-TYROSINE KINASES; RABBITS; RANIDAE; SARCOPLASMIC RETICULUM;

EID: 53049105694     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina44070064     Document Type: Review

References (54)

1. Fatt P, Katz B. The electrical properties of crustacean muscle fibres. J Physiol 1953;120:171-204.
2. Hagiwara S, Ozawa S, Sand O. Voltage clamp analysis of two inward current mechanisms in the egg cell membrane of a starfish. J Gen Physiol 1975;65:617-44.
3. De Waard M, Gurnett CA, Cambell KP. Structural and functional diversity of voltage-activated calcium channels. Ion Channels 1996;4:41-87.
4. Yamakage M, Namiki A. Calcium channels - basic aspects of their structure, function and gene encoding; anesthetic action on the channels - a review. Can J Anesth 2002;49:(2)151-64.
5. Wang M-C, Dolphin A, Kitmitto A. L-type voltage-gated calcium channels: understanding function through structure. FEBS Letters 2004;564:245-50.
6. Bodi I, Mikala G, Koch SE, Akhter SA, Schwartz A. The L-type calcium channel in the heart: the beat goes on. J Clin Invest 2005;115:3306-17.
7. 2+ channels. Cell Physiol Biochem 1999;9:242-69.
8. 2+ channel: perspectives for new pharmacological targets. J Pharmacol Exp Ther 2002;300:724-8.
9. 2+) channels (Ca(V)1.2a,b) by protein kinases. Am J Physiol Cell Physiol 2001;281(6):C1743-56.
10. 2+ channel by electron cryomicroscopy. Proc Natl Acad Sci 2002;99(16):10370-5.
11. Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415:198-205.
12. 2+ channel remodels its own signalling pathway in cardiac cells. Prog Biophys Mol Biol 2006;90:118-35.
13. + regulation in normal and failing hearts. J Pharmacol Sci 2006;100:315-22.
14. Kamp TJ, Hell JW. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ Res 2000;87(12):1095-102.
15. 2+ channels by beta-adrenergic agonists. Proc Natl Acad Sci USA 1996; 93(1):295-9.
16. 2+ release in guineapig cardiac myocytes after b-adrenergic stimulation revealed by two-photon photolysis of caged Ca2+. J Physiol 2005; 565(3):801-13.
17. Hove-Madsen L, Mery P-F, Jurevicius J, Skeberdis AV, Fishmeister R. Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res Cardiol 1996;91(Suppl 2):1-8.
18. Fischmeister R, Castro LR, Abi-Gerges A, Rochais F, Jurevičius J, Leroy J, et al. Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res 2006;99(8):816-28.
19. 2+ current in cardiac myocytes. J Pharmacol Exp Ther 1997;283(2):452-61.
20. Shimoni Y. Hormonal control of cardiac ion channels and transporters. Prog Biophys Mol Biol 1999;72(1):67-108.
21. Brodde OE, Bruck H, Leineweber K. Cardiac adrenoceptors: physiological and pathophysiological relevance. J Pharmacol Sci 2006;100:323-37.
22. 3-adrenoceptor in the human heart. J Clin Invest 1996; 98:556-62.
23. 3-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine. Int J Obes Relat Metab Disord 2002;26:1442-50.
24. De Jongh KS, Murphy BJ, Colvin AA, Hell JW, Takahashi M, Catterall WA. Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3′,5′- cyclic monophosphate-dependent protein kinase. Biochemistry 1996;35:10392-402.
25. 2 subunit of L-type voltage-dependent calcium channels. Biochemistry 1999;38:10361-70.
26. 2+ channels requires membrane targeting of PKA and phosphorylation of channel subunits. Neuron 1997;19:185-96.
27. Mery PF, Abi-Gerges N, Vandecasteele G, Jurevicius J, Eschenhagen T, Fischmeister R. Muscarinic regulation of the L-type calcium current in isolated cardiac myocytes. Life Sci 1997;60:1113-20.
28. Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R. Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nat Med 1999;5:331-4.
29. Mackay K, Mochly-Rosen D. Localization, anchoring, and functions of protein kinase C isozymes in the heart. J Mol Cell Cardiol 2001;33(7):1301-7.
30. Wang QJ. PKD at the crossroads of DAG and PKC signaling. Trends Pharmacol Sci 2006;27(6):317-23.
31. 2+ current from neonatal mouse ventricular myocytes by constitutively active PKC-betaII. Am J Physiol Cell Physiol 2002;282(4):C768-74.
32. Yue Y, Qu Y, Boutjdir M. Beta- and alpha-adrenergic cross-signaling for L-type Ca current is impaired in transgenic mice with constitutive activation of epsilon PKC. Biochem Biophys Res Commun 2004;314(3):749-54.
33. 2+ channel by Gq-activating neurotransmitters reconstituted in Xenopus oocytes. J Biol Chem 2004;279(13): 12503-10.
34. McHugh D, Sharp EM, Scheuer T, Catterall WA. Inhibition of cardiac L-type calcium channels by protein kinase C phosphorylation of two sites in the N-terminal domain. Proc Natl Acad Sci USA 2000;97:12334-8.
35. 2+ channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice. Cardiovasc Res 2003;60(2):268-77.
36. Wang Y, Wagner MB, Joyner RW, Kumar R. cGMP-dependent protein kinase mediates stimulation of L-type calcium current by cGMP in rabbit atrial cells. Cardiovasc Res 2000;48(2): 310-22.
37. Fischmeister R, Castro L, Abi-Gerges A, Rochais F, Vandecasteele G. Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels. Comp Biochem Physiol A Mol Integr Physiol 2005;142(2):136-43.
38. 2+ current in human atrial myocytes by insulin. Cardiovasc Res 1999;44(2):390-7.
39. 2+ currents in cells that have survived in epicardial border zone of canine infarcted heart. J Cardiovasc Pharmacol 2002; 40(5):669-77.
40. Kanaporis G, Skeberdis AV, Gendviliene V, Jurevičius J. Effect of genistein, tyrosine kinase inhibitor, on L-type calcium current in human atrial myocytes. Acta Medica Lituanica 2001;8(2):98-104.
41. 2+ channels. Cardiovasc Res 2005;65(1):28-39.
42. 2+ release at the T-tubules and surface membrane of rat ventricular myocytes. Circ Res 2004;95:1-7.
43. 2+ channels. Prog Biophys Mol Biol 2006;90:104-17.
44. 2+ release by the sarcoplasmic reticulum. J Mol Cell Cardiol 1999; 31:1783-93.
45. Linz KW, Meyer R. Profile and kinetics of L-type calcium current during the cardiac ventricular action potential compared in guinea-pigs, rats and rabbits. Pfluegers Arch 2000; 439:588-99.
46. Noble S, Shimoni Y. The calcium and frequency dependence of the slow inward current 'staircase' in frog atrium. J Physiol 1981;310:57-75.
47. 2+ channel activity: mechanisms and implication in force-frequency relation. Basic Res Cardiol 1998;93(1):51-9.
48. Yuan W, Bers DM. Ca-dependent facilitation of cardiac Ca current is due to Ca-calmodulin-dependent protein kinase. Am J Physiol Heart Circ Physiol 1994;267:H982-93.
49. 2+ signals for facilitation. J Cell Biol 2005;171(3):537-47.
50. Barrere-Lemaire S, Piot C, Leclercq F, Nargeot J, Richard S. Facilitation of L-type calcium currents by diastolic depolarization in cardiac cells: impairment in heart failure. Cardiovasc Res 2000;47:336-49.
51. Pangonyte D, Stalioraityte E, Kazlauskaite D, Žiuraitiene R, Stanioniene Z, Kerpauskiene S. Sergančiuju išemine širdies liga širdies geometrijos pokyčiai. (Changes of heart geometry in patients with ischemic heart disease.) Medicina (Kaunas) 2008;44(1):8-14.
52. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of β-adrenergic signaling in heart failure? Circ Res 2003;93:896-906.
53. Milvidaite I, Lukşiene D, Šlapikiene B, Babarskiene MR, Liukaitis V, Mačiulaitis R, et al. Antrine išemines širdies ligos profilaktika persirgus miokardo infarktu (medikamentinio gydymo ivertinimas remiantis anketines apklausos duomenimis). (Secondary prevention of ischemic heart disease: pharmacological treatment after myocardial infarction according to follow-up protocol.) Medicina (Kaunas) 2007;43(2): 131-6.
54. 2+ channels in the presence of non-hydrolysable ATP analogs. Biologija 2004;2(2 Suppl):36-9.